G202-0426 Screening compound: 4-[(furan-2-yl)methyl]-10-methyl-3-oxo-N-[3-(propan-2-yloxy)propyl]-2H,3H,4H,5H,10H-[1,4]thiazepino[7,6-b]indole-5-carboxamide

G202-0426 Screening compound: 4-[(furan-2-yl)methyl]-10-methyl-3-oxo-N-[3-(propan-2-yloxy)propyl]-2H,3H,4H,5H,10H-[1,4]thiazepino[7,6-b]indole-5-carboxamide
G202-0426 Screening compound: 4-[(furan-2-yl)methyl]-10-methyl-3-oxo-N-[3-(propan-2-yloxy)propyl]-2H,3H,4H,5H,10H-[1,4]thiazepino[7,6-b]indole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G202-0426
4-[(furan-2-yl)methyl]-10-methyl-3-oxo-N-[3-(propan-2-yloxy)propyl]-2H,3H,4H,5H,10H-[1,4]thiazepino[7,6-b]indole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G202-0426

Molecular Formula

C24H29N3O4S (C24 H29 N3 O4 S)

Compound Name

4-[(furan-2-yl)methyl]-10-methyl-3-oxo-N-[3-(propan-2-yloxy)propyl]-2H,3H,4H,5H,10H-[1,4]thiazepino[7,6-b]indole-5-carboxamide

IUPAC name

4-[(furan-2-yl)methyl]-10-methyl-3-oxo-N-[3-(propan-2-yloxy)propyl]-2H3H4H5H10H-[14]thiazepino[76-b]indole-5-carboxamide

SMILES

CC(C)OCCCNC(C(c(c(cccc1)c1n1C)c1SC1)N(Cc2ccco2)C1=O)=O

InChI

InChI=1S/C24H29N3O4S/c1-16(2)30-13-7-11-25-23(29)22-21-18-9-4-5-10-19(18)26(3)24(21)32-15-20(28)27(22)14-17-8-6-12-31-17/h4-6,8-10,12,16,22H,7,11,13-15H2,1-3H3,(H,25,29)/t22-/m0/s1

InChI Key

BTFAZRYPAWXRFT-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD14985238

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.58

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.050

Distribution Coefficient, logD

3.050

Water Solubility, LogSw

-3.20

Polar Surface Area

56.664

Acid Dissociation Constant (pKa)

14.79

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

41.70

G202-0426 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Cyclic Ugi PPI Library (9586 compounds)

DGK Inhibitors Library (10558 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Peptidomimetic Library (37031 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with G202-0426 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G202-0426?
Check Price and Availability of G202-0426, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G202-0426 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G202-0426
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G202-0426
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G202-0426 available by request